Age Related Macular Degeneration

AMD has two forms - wet and dry. Below is an overview of wet and dry AMD

What is the Macula?

The macula is the center part of the retina that we look straight ahead with. The eye works like a camera. The retina is like the film in the back of a camera. The center of the retina is called the macula. When you look at someone's face or read a book, you are using your macula. That is where your fine vision is. The rest of the retina is for the side or peripheral vision. You cannot see well with your peripheral vision, but you can get around and function with your peripheral vision. Macular degeneration can cause central vision loss, but never causes loss of peripheral vision (side vision).

What is Dry Macular Degeneration?

Dry AMD occurs when drusen develop in the macula (see photo). Most people with dry AMD have normal or near normal vision. Only about 10 percent develop advanced dry AMD. Advanced dry AMD occurs when the retina thins out so much that the vision declines. We call the thin spots geographic atrophy. We recommend vitamins for patients with dry AMD and fish oil. Patient with dry AMD should follow their vision and amsler grid every day and report to their physician if their is a change in vision in either eye or a change on the amsler grid. It is very important to check each eye separately.

Read more

What is Wet Macular Degeneration?

Wet AMD occurs when blood vessels start to grow in the macula. These blood vessels can also grow with scar tissue and blood (see photo). Untreated, most people with wet AMD lose their central vision. With treatment, the disease progression can usually be stopped and often reversed. Promt treatment leads to the best results, so if you have a sudden change in vision that could be a sign of wet AMD, you should see your physician urgently.

Read more

Macular Degeneration NEWS

Below are current articles from a Google News Feed on Macular Degeneration

Carl Regillo, MD: Brolucizumab as a Treatment for Macular Degeneration  MD Magazine

Investigators from Wills Eye and Retina Consultants of Austin presented 96-week data from the HAWK and HARRIER trials at ASRS 2019.

Risuteganib for Patients with Dry Age-Related Macular Degeneration  MD Magazine

Peter Kaiser, MD, presented data from a phase 2 trial examining the safety and efficacy of risuteganib at ASRS 2019.

Treating age-related macular degeneration  WDTN.com

"It's probably the most common diagnosis I see here in my practice," says Retinal Specialist Dr. Joshua Mali.

Expert panel in macular degeneration recommends paradigm shift for future directions  Medical Xpress

A panel of investigators assembled by the National Advisory Eye Council (NAEC) calls for large-scale collaborative research to address dry macular ...

Global Wet Age-Related Macular Degeneration Markets, 2014-2018 & 2019-2024 - Positive Clinical Trial Results and Increasing Approvals for Pipeline Drugs  PRNewswire

DUBLIN, Aug. 6, 2019 /PRNewswire/ -- The "Wet Age-Related Macular Degeneration Market by Product, by Distribution Channel, by Age Group, by Route of ...

Joshua Mali, MD: Evolution of Care for Macular Degeneration  MD Magazine

Medical Director of the Macular Degeneration Association discusses how the evolution of anti-VEGF treatments has changed the landscape of AMD care and ...

Biweekly Dosing for Refractory Neovascular Age-Related Macular Degeneration  MD Magazine

Results of a study presented at ASRS 2019 found that biweekly anti-VEGF dosing may be an effective treatment for treating nAMD refractory to standard monthly ...

Report: Dry AMD requires broad, systems biology approach leveraging big data, multiple disciplines  National Institutes of Health

A large-scale, collaborative, systems biology approach is needed to expedite the discovery of treatments for dry age-related macular degeneration (AMD) – a ...

Intraoperative surgical methods hold key to AMD treatment  Modern Retina

Intraoperative fundus image and intraoperative OCT obtained with a commercially available operating microscope (OPMI LUMERA 700 and RESCAN 700; Carl ...

The huge unmet medical need of dry AMD is expected to drive the market at a CAGR of over 8% during the forecast period  Yahoo Finance

NEW YORK , July 24, 2019 /PRNewswire/ -- Global Age-Related Macular Degeneration (AMD) Therapeutics Market: About this market Read the full report: ...

Kodiak's AMD med posts promising phase 1b data in 3 eye diseases  FierceBiotech

Eylea and Kodiak's KSI-301 are both anti-VEGF biologics injected into the eye. But KSI-301 has a longer half-life, meaning that patients could go longer between ...

Use of bevacizumab and ranibizumab for wet age-related macular degeneration: Influence of CATT results and introduction of aflibercept  MD Linx

In this retrospective analysis of treatment patterns, researchers ascertained if publication of Comparison of Age-related macular degeneration Treatment Trial ...

A Patient’s Guide to Eye Disease  U.S. News & World Report

Learn about common eye diseases, as well as the symptoms, causes and treatment options, at U.S. News and World Report.

Live at 9: WREG Blood Drive, Our Boys Need Us & macular degeneration 101  WREG NewsChannel 3

Check out all the Live at 9 interviews from Thursday, August 1, 2019.

Novartis teams with celeb designer Berkus for AMD push—and home tips, too  FiercePharma

TV personality and interior designer Nate Berkus teamed with Novartis for helpful at-home tips for people with age-related macular degeneration, such as ...

Lawrence Hoffheimer: Legal Hurdles for Retina Specialists  MD Magazine

A former D.C. healthcare attorney and founder of the Macular Degeneration Association discusses legal problems faced by retina specialists when providing ...

Stem Cells and Health Advances: Where Are We Now?  WebMD

Treatments for eye diseases are considered among the most promising for stem cells, which have been under study for more than 3 decades. While proponents ...

FDA approves Eylea prefilled syringe  Healio

The FDA has approved a chemistry, manufacturing and controls prior-approval supplement for the Eylea injection prefilled syringe, Regeneron announced in a ...

Allegro Ophthalmics to Present for the First Time the Results of Its Phase 2 Risuteganib Intermediate Dry Age-Related Macular Degeneration Study at the ASRS Annual Meeting 2019  Yahoo Finance

Risuteganib Met Visual Acuity Primary Endpoint with Statistical Significance in U.S. Phase 2 Trial.

Bionic eye helps people who are blind read letters again  New Scientist

A bionic eye has helped people who are legally blind to see and read letters again. The device consists of glasses with an embedded camera, and a microchip ...

Scientists make major breakthrough in understanding common eye disease  Science Daily

Scientists have announced a major breakthrough with important implications for sufferers of a common eye disease -- dry Age-Related Macular Degeneration ...

We should establish a National Institute of Nutrition  USA TODAY

Obesity is one of the leading threats to the U.S. health care system. The government should allocate more money to nutrition research that can help.

Interesting Sessions to Come at ASRS 2019  MD Magazine

Here's a primer for new data and discussions MD Mag will be covering this weekend in Chicago.

LumiThera raises cash for medical device that uses light to fight vision loss  GeekWire

Medical device startup LumiThera raised $1.15 million as part of a new fundraising round, according to a new SEC filing. The Poulsbo, Wash.-based company is ...

Novartis teams with interior designer to help wet AMD patients  PharmaLive

Written by: Administrator | admin@medadnews.com | Dated: Sunday, August 11th, 2019. Novartis is teaming up with celebrity interior designer Nate Berkus to ...

Nate Berkus Designing Homes for Vision Impaired  Healthline

The interior designer and co-host of “Nate & Jeremiah by Design” shares his ideas for home updates that can make spaces safer — without sacrificing style ...

Global Juvenile Macular Degeneration Treatment Market 2019 – Acucela Inc., Alkeus Pharmaceuticals Inc, Astellas Pharma Inc – SocioHerald  SocioHerald

The Global Juvenile Macular Degeneration Treatment market report examines the trends of assumptions, key incentives, successful expansion capabilities, ...

Electrical channels in retina could play role in degenerative diseases  Drug Target Review

Researchers have discovered electrical channels important in sensory cell renewal which could be studied further to develop therapies for retinal diseases.

Physicians' Perspective: Desired Changes Among Retina Specialists  MD Magazine

Carl Regillo, MD, of Wills Eye, and Michael Stewart, of the Mayo Clinic, discuss changes they would like to see in their speciality at ASRS 2019.

Can Supplements Improve Eye Health and Vision?  Michigan Medicine

Kellogg Eye Center ophthalmologists explain which vitamins and supplements are actually good for your eyes.

Congress and Wall Street can move disease research closer to treatments, cures | TheHill  The Hill

With new funding mechanisms to push research ahead, there is no doubt the science and technology capabilities exist to deliver more breakthroughs for eye ...

Systems biology approach needed for dry AMD research  Healio

Finding treatments for dry age-related macular degeneration requires a large-scale, collaborative, systems biology approach. Dry AMD, which currently has no ...

5 Biggest New Drug Approvals Potentially on the Way in 2019  Yahoo Finance

FDA approvals for these drugs could translate to billions of dollars for a few companies.

This groundbreaking bionic eye system restores lost vision with a retina chip  Digital Trends

Clinical trials of a pair of smartglasses designed to help legally blind people to see and read letters again are currently taking place in two cities in the United ...

Temporal inverted ILM flap technique improves macular hole repair in wet or dry AMD eyes  Healio

CHICAGO — Patients coexisting with dry or wet age-related macular degeneration and macular holes experienced improved vision, anatomic and functional ...

Caldwell's life took him down farming path | News  Post Register

GIBSON – Although he grew up on his parents' ranch and helped with the cattle and growing the crops needed to see them through the winter, Mike Caldwell ...

Eye on Pharma: FDA Gives Green Light to Aflibercept in Prefilled Syringe  The Center for Biosimilars

Regeneron's aflibercept (Eylea) has been approved by the FDA for a prefilled syringe (PFS) presentation. The 2-mg, single-dose, PFS will offer the greater ease ...

Seeing eye to eye  Dailyuw

The average American adult spends over 11 hours a day looking at a screen. The average teen, around 9 hours. And it's only on the rise.

At 2 years, aflibercept injections did not impact CNV conversion rates  Healio

CHICAGO — The 24-month results of the PRO-CON study did not demonstrate a benefit of intravitreal aflibercept injection as prophylaxis against the conversion ...

FDA Unveils Graphic Health Warnings It Wants To Add To Cigarette Packages To Deter Smoking  CBS Philly

CrePHILADELPHIA (CBS) — The FDA has unveiled graphic health warnings it wants to add to cigarette packages and labels to deter people from smoking.

Long term exposure Vehicle exhaust pollutants increases risk of age related macular degeneration  Specialty Medical Dialogues

Exposure to the highest levels of air pollutants was associated with an almost doubling in risk among those aged 50 and older, finds a new study. Long term ...

Peddling unproven treatments, stem cell industry ‘fleeces,’ sometimes harms patients  Kansas City Star

Stem cell clinics in Kansas City and across America charge thousands of dollars to treat everything from arthritis to erectile dysfunction to multiple sclerosis.

Eye's vulnerability to macular degeneration revealed  Medical Xpress

Scientists have found significant differences in the shape and biology of the same type of cell taken from different parts of the retina, according to a study in eLife.

Review of Neovascular Age-Related Macular Degeneration Treatment Options  AJMC.com Managed Markets Network

Due to an aging population, visual impairment from neovascular age-related macular degeneration (nAMD) is increasing in the United States. Despite ...

7 Tips to Stop Macular Degeneration  Healthline

Macular degeneration is one of the leading causes of blindness in the United States. Here's how to keep your vision safe while enjoying the sun this spring ...

Last trial OKed for Eylea to prevent blindness in premature infants  Korea Biomedical Review

The Korean drug regulator has approved a phase-3 clinical trial on Eylea (ingredient: aflibercept), an anti-vascular endothelial growth factor (anti-VEGF) ...

FDA Action Alert: Regeneron, Kala and Vanda  BioSpace

Now that July has come and gone, the U.S. Food and Drug Administration is back to work approving drugs. This week marks three PDUFA target action dates, ...

What Is Age-Related Macular Degeneration?  Next Avenue

Age-related macular degeneration (AMD) causes deterioration of the macula, the part of the eye that provides sharp, clear, straight-ahead vision. As many Here ...

Implanted drug 'reservoir' safely reduces injections for people with macular degeneration  EurekAlert

In a clinical trial of 220 people with 'wet' age-related macular degeneration, Johns Hopkins Medicine researchers, collaborators from many sites across the ...

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2019 Recipient of RPB David F. Weeks Award for Outstanding AMD Research  Newswise

Newswise — SAN FRANCISCO, CA and NEW YORK, NY, August 12–Christine Curcio, PhD, has been selected as the 2019 RPB David F. Weeks Award for ...

What Is the Difference Between Wet or Dry Macular Degeneration?  University of Michigan Health System News

Dry macular degeneration occurs when cells of the macula begin to thin and break down. It is characterized by drusen buildup and typically worsens over time.

Researchers discover new biomarker for age-related macular degeneration  Medical Xpress

Researchers from the University of Alabama at Birmingham Department of Ophthalmology and Visual Sciences, along with collaborators from the University of ...

Terry Jean Farrier  Tulsa World

Terry Jean Farrier, age 75, passed away in her sleep here in her hometown of Tulsa, Oklahoma on August 12, 2019.

7 Healthy Habits to Help Prevent Macular Degeneration  University of Michigan Health System News

AMD affects the eyesight of millions. A Michigan Medicine specialist offers easy ways to help slow or prevent the disease.

Bionic vision system works with augmented reality glasses  Tech Xplore

A company focused on a bionic vision system sees hope for improvements in patients by means of a wireless sub-retinal implant together with augmented reality ...

What you need to know about wet macular degeneration  Medical Xpress

Millions of people deal with age-related macular degeneration as they get older, but many don't understand the difference between types of the condition or ...

Bionic vision system restores sight in AMD trials  The Engineer

Five people suffering from age-related macular degeneration (AMD) have been able to read letters again, following trials of a bionic vision system.

Treatment for Wet Age-Related Macular Degeneration Receives Biologics License Application Approval  Pharmacy Times

Officials with the FDA have accepted Novartis' Biologics License Application (BLA) for brolucizumab (RTH258), a humanized single-chain antibody fragment ...

Sight loss support group set up in Banff Sight loss support group set up in Banff  Grampian Online

A new support group which aims to help increase the confidence and independence of people affected by sight loss is set to meet once a month in Banff.

Personalized 'eye-in-a-dish' models reveal genetic underpinnings of macular degeneration  Science Daily

Using stem cells derived from six people, researchers recapitulated retinal cells in the lab. This 'eye-in-a-dish' model allowed them to identify genetic variants ...

Finnish discovery brings new insight on the functioning of the eye and retinal diseases  EurekAlert

Finnish researchers have found cellular components in the epithelial tissue of the eye, which have previously been thought to only be present in electrically ...

Age-Related Macular Degeneration: 5 Things to Know  Medscape

A guide to the latest on this chronic disease, from emerging treatments to the risk factors to be on the lookout for.

An alternate theory for what causes Alzheimer's disease  UC Riverside

A UC Riverside study points to lysosomal storage observed in all brains afflicted with the disease; finding could open up new avenues for treatment and ...

Complement system and age-related macular degeneration: drugs and chal | DDDT  Dove Medical Press

Jiali Wu,1 Xiaodong Sun1–3 1Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ...

Learning About nAMD Treatment from Individual Responses  MD Magazine

Early treatment and completing treatments key to visual acuity improvements in neovasculare age-related macular degeneration.

Reducing the psychological distress of patients diagnosed with a common, retinal disease  EurekAlert

A new study from City, University of London suggests that effective communication from eye health professionals may help reduce patient fears after they are ...

Age-related Macular Degeneration Market Competitive Landscape Analysis with Forecast by 2025  NewsRegal

The market for AMD is driven by increasing number of AMD patients throughout the world. According to the American Academy of Ophthalmology, in the U.S., ...

Cutting Edge Research Grants Announced by The American Macular Degeneration Foundation  Newswise

Vision research foundations combine resources to support macular degeneration investigations with the potential to produce new treatments.

Ocular Vitamins Market to Witness Surge in Demand Owing to Rising End-use Adoption  Wolf Mirror

Ocular Vitamins are the vitamins, which are used to maintain the health of the eye. There are many vitamins such as vitamin A, vitamin C, vitamin E, vitamin B6, ...

Vitamins, new treatments offer hope for people with macular degeneration  nwitimes.com

Macular degeneration is the leading cause of vision loss, affecting more than 10 million Americans — more than cataracts and glaucoma combined.

Change Within Eye A Hint of Macular Degeneration?  WebMD

The investigators discovered that calcifications in the retina -- the thin layer of tissue that lines the back of the eye -- raise the risk of advanced age-related ...

Age–Related Macular Degeneration Market to Surge at a Robust Pace by 2018 to 2026  Business Intelligence

Age–Related Macular Degeneration Market is expected to have a highly positive outlook for the next five years 2018–2026 according to a recently released ...

Breakthrough in identifying new genes in age-related macular degeneration, the leading cause of blindness  Medical Xpress

Fight for Sight funded research published this week in Clinical Epigenetics, has identified new genes linked to the development of age-related macular ...

New laser shows promise in treating macular degeneration  WOWT

A breakthrough treatment for macular degeneration is being used on patients in the Rogue Valley. The Medford office using it is believed to be the only one West ...

Ophthalmology grabs Wall Street's attention  Ophthalmology Times

Editor's Note: Welcome to “Let's Chat,” a blog series featuring contributions from members of the ophthalmic community. These blogs are an opportunity for ...

Protect Your Aging Eyes From Macular Degeneration | Health News  U.S. News & World Report

By Robert Preidt, HealthDay Reporter. (HealthDay). FRIDAY, Feb. 15, 2019 (HealthDay News) -- Age-related macular degeneration (AMD) is an incurable eye ...

Doc: Yellow lenses to the rescue for macular degeneration  The Detroit News

Age-related macular degeneration is the leading cause of vision loss in industrialized countries.

Boosting natural repair could help solve age related macular degeneration  PharmaTimes

Fight for Sight has announced funding for scientists at Queen's University Belfast. - News - PharmaTimes.

Seeing clearly: Know your risk for macular degeneration  Baylor College of Medicine News

Baylor College of Medicine's Dr. Christina Weng discusses what you need to know about macular degeneration.

The best antioxidant foods: List and benefits  Medical News Today

Antioxidants are in many healthful foods. Experts believe that they help the body fight harmful free radicals that can lead to various health conditions. Find out ...

Will blue light from electronic devices increase my risk of macular degeneration and blindness? - Harvard Health Blog  Harvard Health

Every day, retinal specialists are asked about the risks from blue light emitted from electronic devices. (Retinal specialists treat conditions affecting the retina, ...

An Alternate Theory for the Cause of Alzheimer’s Disease  Technology Networks

Alzheimer's disease, the most common cause of dementia among the elderly, is characterized by plaques and tangles in the brain, with most efforts at finding a ...

Trial will be first in US of Nobel-winning stem cell technique  STAT

The NIH is planning the first U.S. clinical trial using induced pluripotent stem cells, to treat age-related macular degeneration.

SOLD-OUT Shows Are Audience Favorites At United Solo's Tenth Anniversary  Broadway World

United Solo, the world's largest solo theatre festival, is bringing together over 130 shows from all over the world for its tenth anniversary. These shows will offer ...

WW2 survivor, 98, appeals for fellow Nazi camp detainees  The Telegraph

A prisoner of war locked up for five years during the Second World War despite two daring escape bids is now searching for any other surviving soldiers from ...

Outlook Therapeutics Provides Business Update and Reports Financial Results for Third Quarter of Fiscal 2019  GlobeNewswire

CRANBURY, N.J., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ: OTLK) (the “Company”) today reported business highlights and ...

Research into new macular degeneration treatments takes off as cases rise  STAT

Scientists are experimenting with dozens of drug candidates, including about 20 in clinical trials, that work to preserve vision and restore sight.

Scientists identify genetic variants that cause macular degeneration  Becker's Hospital Review

A mutation in a gene that supports blood vessel growth can directly contribute to the onset of age-related macular degeneration, according to a study published ...

Using AI to Identify Diabetic Retinopathy and Clinically Significant DME  MD Magazine

Artificial intelligence could be the future of detecting certain diseases in the eye, after a study presented at ASRS 2019 found that the EyeArt system was effective ...

Research Advances Towards Eye Drop for Age-Related Macular Degeneration  Specialty Pharmacy Times

A team of British scientists is making strides toward its goal of creating an eye drop capable of treating age-related macular degeneration (AMD).

Global Macular Degeneration and Diabetic Retinopathy Drugs Market 2019 Industry Overview, Growth, Top Key Players : Novartis, Bayer Healthcare, Roche, Neurotech Pharmaceuticals  Market Reports

The report on the Global”Macular Degeneration and Diabetic Retinopathy Drugs“offers detailed data on the Macular Degeneration and Diabetic Retinopathy ...

Genes Linked to Age-related Macular Degeneration  Technology Networks

National Eye Institute scientists led a collaborative study and zeroed in on genes associated with age-related macular degeneration (AMD), a leading cause of ...

Preventing Progression in Nonexudative Age-Related Macular Degeneration With Subthreshold Laser Therapy: A Systematic Review  Healio

Ophthalmic Surgery, Lasers and Imaging Retina | BACKGROUND AND OBJECTIVE:Age-related macular degeneration (AMD) is the leading cause of ...

Guardion Health Sciences Closes $5.8 Million Underwritten Public Offering  Yahoo Finance

San Diego, CA , Aug. 15, 2019 -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), today announced the closing of its previously ...

Better assessments for early age-related macular degeneration  Medical Xpress

The European MACUSTAR consortium is conducting a multi-country clinical study on age-related macular degeneration (AMD) coordinated by the University of ...

TMR's Recent Publication includes an Extensive Analysis on the Ocular Drug Delivery Technology Market  ScoopJunction

This report on the Global Ocular Drug Delivery Technology market analyzes the current and future scenario of the global market. Rise in private and public ...

Take steps to prevent vision loss from macular degeneration  Buffalo News

By Judith Whitehead – Contributing Writer Age-related macular degeneration is the leading cause of blindness among older Americans but treatments have ...

Age Related Macular Degeneration Treatment Market Global Industry Analysis and Forecast till 2025  Market Reporter

This report presents the worldwide Age Related Macular Degeneration Treatment market size (value, production and consumption), splits the breakdown (data ...

Gene Therapy for the Most Common Form of Blindness Gets Its First Human Test  Gizmodo

An 80-year-old woman from the United Kingdom is the first patient to undergo gene therapy to treat age-related macular degeneration—the most common cause ...

Stealth BioTherapeutics Reports First Half 2019 Financial Results And Recent Business Highlights  Yahoo Finance

Louis Lange M.D., Ph.D. joins Board BOSTON , Aug. 14, 2019 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology ...

» Load more

What about Resources?

Dr. Pautler's Blog
American Academy of Ophthalmology
MedlinePlus
National Institutes of Health
  • ARMD
    NIH's SeniorHealth website covers the topic of Age-Related Macular Degeneration
National Eye Institute
American Foundation for the Blind - Senior Site
  • Macular Degeneration
    Basic information about AMD and low vision; includes a self-test using an Amsler Grid
Journal of the American Medical Association (JAMA)
WebMD
LightHouse International
  • Macular Degeneration
    Provides a general overview of the basics of AMD, and a simulation showing a scene as it might be viewed by a person with AMD
Prevent Blindness America